Abstract:To further imporve the quality control mechanism of the bulk drug of butylphthalide APIs and enhance drug safety, a high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method was established for the accurate determination of six potential genotoxic impurities in butylphthalide bulk drug. The separation was performed on a Waters XBridge C18 column (250 mm × 4.6 mm, 5 μm) with gradient elution using 005% formic acid in water (A) and methanol (B) as the mobile phase. Mass spectrometry was conducted with electrospray ionization (ESI) in negative ion multiple reaction monitoring (MRM) mode for the quantitative detection of the six genotoxic impurities including 5-bromo-3-hydroxyisobenzofuran-1(3H)-one, 4-bromo-3-hydroxyisobenzofuran-1(3H)-one, 6-bromo-3-hydroxyisobenzofuran-1(3H)-one, 3-bromo-2-formylbenzoic acid, 5-bromo-2-formylbenzoic acid and 4-bromo-2-formylbenzoic acid in butylphthalide bulk drug. The results demonstrate excellent linearity of three genotoxic impurities, including impurity L、impurity N and impurity G, within the mass concentration ranges of 0.019 6~0.196 2 ng, 0.020 4~0.203 2 ng and 0.021 2~0.212 4 ng, respectively (r ≥ 0.998 0, n=6), with a limit of quantitation of 0.019 6~0.021 2 ng, and an average recovery of 1.039%~1.055%. The established method is applied to three batches of APIs, with no detectable levels of the six potential genotoxic impurities. The analytical method for butylphthalide genotoxic impurities described herein is simple to operate, accurate in quantification, and highly specific, making it suitable for the detection of these six impurities in butylphthalide APIs. The method can serve as a reference for the detection of genotoxic impurities in other pharmaceuticals.